| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening
|
Zhang, Jing-Ping
|
|
|
134 |
2 |
p. 171-185
|
artikel
|
| 2 |
A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
|
Mikhael, Joseph
|
|
|
134 |
2 |
p. 123-133
|
artikel
|
| 3 |
Calming the storm in HLH
|
Zinter, Matt S.
|
|
|
134 |
2 |
p. 103-104
|
artikel
|
| 4 |
Deconstructing myelodysplastic syndromes
|
del Rey Gonzalez, Monica
|
|
|
134 |
2 |
p. 106-107
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
134 |
2 |
p. i
|
artikel
|
| 6 |
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
|
Roberts, Andrew W.
|
|
|
134 |
2 |
p. 111-122
|
artikel
|
| 7 |
Facing lenalidomide-refractory myeloma
|
Cavo, Michele
|
|
|
134 |
2 |
p. 99-101
|
artikel
|
| 8 |
Finding Neo (antigens, that is)
|
Olweus, Johanna
|
|
|
134 |
2 |
p. 108-109
|
artikel
|
| 9 |
Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure
|
Chen, Yi-Bin
|
|
|
134 |
2 |
p. 211-215
|
artikel
|
| 10 |
Marked lymphocytosis and atypical cells with a cleft nucleus in a 1-month-old child
|
Rieu, Jean-Baptiste
|
|
|
134 |
2 |
p. 216
|
artikel
|
| 11 |
Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis
|
Albeituni, Sabrin
|
|
|
134 |
2 |
p. 147-159
|
artikel
|
| 12 |
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms
|
Schischlik, Fiorella
|
|
|
134 |
2 |
p. 199-210
|
artikel
|
| 13 |
Novel pathways of self- and cross-tolerance in monocytes
|
Farsky, Sandra H.P.
|
|
|
134 |
2 |
p. 101-103
|
artikel
|
| 14 |
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs
|
Sperling, Adam S.
|
|
|
134 |
2 |
p. 160-170
|
artikel
|
| 15 |
Quest of biomarkers for venetoclax-treated CLL
|
Rossi, Davide
|
|
|
134 |
2 |
p. 97-98
|
artikel
|
| 16 |
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
|
Hsu, Jasper
|
|
|
134 |
2 |
p. 186-198
|
artikel
|
| 17 |
Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation
|
Freise, Nicole
|
|
|
134 |
2 |
p. 134-146
|
artikel
|
| 18 |
Table of contents. Blood. 2019;133(18):iii-iv.
|
|
|
|
134 |
2 |
p. 218
|
artikel
|
| 19 |
The Pandora's box of thalidomide analogs and their substrates
|
Neri, Paola
|
|
|
134 |
2 |
p. 105-106
|
artikel
|
| 20 |
Unusual histiocytes in a pleural effusion: signature of a rare disease
|
El Khoury, Christelle
|
|
|
134 |
2 |
p. 217
|
artikel
|
| 21 |
Ward-Caviness CK, Huffman JE, Everett K, et al. DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis. Blood. 2018;132(17):1842-1850.
|
|
|
|
134 |
2 |
p. 218
|
artikel
|
Tijdschrift beschrijving